Clinical Trial

FIM Study of the LAmbre™ II LAA Occluder in Non-Valvular AF Patients

Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the preliminary safety and feasibility of the LAmbreTM II Left Atrial Appendage Occluder and the Occluder Delivery System in patients with non-valvular atrial fibrillation who are at increased risk for stroke and systemic embolism.
Protocol Amendment History 1 change
critical Trial status changed: Active, Not Recruiting → Recruiting 2026-06-11
Trial Details
NCT Number NCT07385599
Lead Sponsor Lifetech Scientific (Shenzhen) Co., Ltd.
Conditions Non-valvular Atrial Fibrillation (NVAF)
Enrollment 10 participants
Start Date 2026-01-19
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-10